Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|March 14, 2012
Risk analysis of analytical validations by probabilistic modification of FMEAD M Barends, M T Oldenhof, M J Vredenbregt, et al.Journal of Pharmaceutical and Biomedical Analysis|April 5, 2008
Detection of Lipitor counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometricsP de Peinder, M J Vredenbregt, T Visser, et al.Journal of Pharmaceutical and Biomedical Analysis|September 29, 2009
The identification of (-)-trans-tadalafil, tadalafil, and sildenafil in counterfeit Cialis and the optical purity of tadalafil stereoisomersB J Venhuis, G Zomer, M J Vredenbregt, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 7, 2003
Choice and validation of a near infrared spectroscopic application for the identity control of starting materials. practical experience with the EU draft Note for Guidance on the use of near infrared spectroscopy by the pharmaceutical industry and the data to be forwarded in part II of the dossier for a marketing authorizationM J Vredenbregt, P W J Caspers, R Hoogerbrugge, et al.Journal of Pharmaceutical and Biomedical Analysis|October 19, 2005
Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopyM J Vredenbregt, L Blok-Tip, R Hoogerbrugge, et al.The Analyst|December 1, 1994
Confirmational analysis of beta-agonists by cryotrapping gas chromatography-Fourier transform infrared spectrometryT Visser, M J Vredenbregt, A P de Jong, et al.Journal of Pharmaceutical and Biomedical Analysis|July 31, 2009
Risk analysis by FMEA as an element of analytical validationJ F van Leeuwen, M J Nauta, D de Kaste, et al.Journal of Pharmaceutical and Biomedical Analysis|October 26, 2010
Consistency of FMEA used in the validation of analytical proceduresM T Oldenhof, J F van Leeuwen, M J Nauta, et al.Pageof 1